Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China flag China · Delayed Price · Currency is CNY
5.21
-0.26 (-4.75%)
Sep 10, 2026, 3:04 PM CST

SHE:002099 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-169.67-91.08-330.27-420.0688.0195.23
Depreciation & Amortization
338.52340.92342.76364.6336.52294.23
Other Amortization
1.461.811.561.170.460.26
Loss (Gain) From Sale of Assets
-0.19-0.03-1.04-12.88-0.291.48
Asset Writedown & Restructuring Costs
72.21-1.57242.85132.8260.16-0.55
Loss (Gain) From Sale of Investments
-71.76-23.8827.6883.9227.27-9.8
Provision & Write-off of Bad Debts
1.512.824.54-13.4117.5310.08
Other Operating Activities
150.62136.1152.39171.89-36.161.59
Change in Accounts Receivable
-324.35-163.71-340.32.74-229.76-754.98
Change in Inventory
-138.36-186.96-264.23293.73-213.74-194.08
Change in Accounts Payable
121.95-77.68347.63-316.5267.64601.96
Operating Cash Flow
-22.93-59.68174.83240.54116.09102.36
Operating Cash Flow Growth
---27.32%107.19%13.41%-80.83%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-68-74.46-122.11-153.08-179.42-229.56
Sale of Property, Plant & Equipment
9.339.258.0924.345.669.23
Divestitures
-----0.16
Investment in Securities
-35.75-13.2824-40.5-459.13-254
Other Investing Activities
155.83386.12-437.3741.0312.58-34.84
Investing Cash Flow
61.41307.63-527.39-128.21-620.32-509.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-2,4532,5072,3072,2281,069
Total Debt Issued
1,9512,4532,5072,3072,2281,069
Long-Term Debt Repaid
--2,544-2,591-2,321-1,822-934.76
Lease Payments
-3.35-6.17-5.06-5.45-5.05-5.76
Total Debt Repaid
-2,380-2,544-2,591-2,321-1,822-934.76
Net Debt Issued (Repaid)
-428.77-91.73-84.56-14.51406.11134.24
Repurchase of Common Stock
-26.09-26.09-151.42---
Common Dividends Paid
-25.15-26.29-28.06-118.94-195.44-53.45
Other Financing Activities
2.81247.14267.5232.52-332.55-
Financing Cash Flow
-477.2103.023.4699.07-121.8880.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-60.17-29.1335.691.175.13-25.53
Net Cash Flow
-498.9321.85-313.4212.5-550.97-351.39

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-90.93-134.1452.7387.46-63.33-127.2
Free Cash Flow Growth
---39.72%---
Free Cash Flow Margin
-4.64%-7.21%2.72%4.03%-2.34%-5.12%
Free Cash Flow Per Share
-0.06-0.090.030.05-0.04-0.08
Levered Free Cash Flow
254.522.41237.44202.7877.39401.47
Unlevered Free Cash Flow
262.1519.45255.44226.38100.23415.15
Free Cash Flow After Leases
-94.27-140.3147.6782.01-68.38-132.96

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
--34.97-36.96-19.73-88.149.28
Change in Working Capital
-345.63-424.78-265.66-67.52-377.46-350.16